The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s
In a population-based study survival after recurrence was compared in three cohorts of patients with a primary diagnosis of breast cancer in 1959, 1969 and 1979, respectively. The use of chemotherapy after recurrence in these cohorts was either none, sporadic or widespread. This allowed a retrospect...
Gespeichert in:
| Veröffentlicht in: | European journal of cancer (1990) 1993, Vol.29 (8), p.1146-1152 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1152 |
|---|---|
| container_issue | 8 |
| container_start_page | 1146 |
| container_title | European journal of cancer (1990) |
| container_volume | 29 |
| creator | Cold, Søren Jensen, Niels V. Brincker, Hans Rose, Carsten |
| description | In a population-based study survival after recurrence was compared in three cohorts of patients with a primary diagnosis of breast cancer in 1959, 1969 and 1979, respectively. The use of chemotherapy after recurrence in these cohorts was either none, sporadic or widespread. This allowed a retrospective analysis of the survival impact of chemotherapy. Given the basic assumption that the natural history of breast cancer and the influence of endocrine therapy have not changed significantly during the 20-year period covered by the study, our data suggest that chemotherapy in recurrent breast cancer prolongs survival by 9.5 months in patients who survive more than 2 weeks from the start of treatment for their recurrence. |
| doi_str_mv | 10.1016/S0959-8049(05)80305-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75804083</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959804905803053</els_id><sourcerecordid>75804083</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-f1841c7735436c24316a2cf3bb7d64c1760eaedea44319bf4184e175ef28f8f43</originalsourceid><addsrcrecordid>eNqFUc1u1DAYtBCobAuPUMknBFIDnxM7dk6oqviTKnGgnC3H-aw1ysbBdlbaGw_BgefjSXB2V71y-mzPzDfyDCHXDN4yYO27b9CJrlLAu9cg3ihoQFTNE7JhSnYVKFE_JZtHynNymdIPAJCKwwW5UIIpqMWG_HnYIvWTGxecLNLgqN3iLuQtRjMfaJhoWuLe781IjcsYaUS7xHgk-4n2EU3K1Jpyj39__TZ0DvMymuzDVPUm4UBTXobDungurzjlRHMR5YIUffGhrBOQbspoIVEzDeUkIb0gz5wZE748zyvy_eOHh7vP1f3XT1_ubu8ry4XIlWOKMytlI3jT2po3rDW1dU3fy6HllskW0OCAhheo6x0vfGRSoKuVU443V-TVae8cw88FU9Y7nyyOo5kwLElLUfID1RSiOBFtDClFdHqOfmfiQTPQayP62Ihe49Yg9LERvequzwZLv8PhUXWuoODvTziWX-49Rp2sX_MdfMk66yH4_zj8AyHbnG0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75804083</pqid></control><display><type>article</type><title>The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Cold, Søren ; Jensen, Niels V. ; Brincker, Hans ; Rose, Carsten</creator><creatorcontrib>Cold, Søren ; Jensen, Niels V. ; Brincker, Hans ; Rose, Carsten</creatorcontrib><description>In a population-based study survival after recurrence was compared in three cohorts of patients with a primary diagnosis of breast cancer in 1959, 1969 and 1979, respectively. The use of chemotherapy after recurrence in these cohorts was either none, sporadic or widespread. This allowed a retrospective analysis of the survival impact of chemotherapy. Given the basic assumption that the natural history of breast cancer and the influence of endocrine therapy have not changed significantly during the 20-year period covered by the study, our data suggest that chemotherapy in recurrent breast cancer prolongs survival by 9.5 months in patients who survive more than 2 weeks from the start of treatment for their recurrence.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/S0959-8049(05)80305-3</identifier><identifier>PMID: 8518025</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Breast Neoplasms - drug therapy ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Cohort Studies ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local - mortality ; Survival Analysis ; Time Factors</subject><ispartof>European journal of cancer (1990), 1993, Vol.29 (8), p.1146-1152</ispartof><rights>1993 Pergamon Press Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-f1841c7735436c24316a2cf3bb7d64c1760eaedea44319bf4184e175ef28f8f43</citedby><cites>FETCH-LOGICAL-c455t-f1841c7735436c24316a2cf3bb7d64c1760eaedea44319bf4184e175ef28f8f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0959804905803053$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,4009,27902,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8518025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cold, Søren</creatorcontrib><creatorcontrib>Jensen, Niels V.</creatorcontrib><creatorcontrib>Brincker, Hans</creatorcontrib><creatorcontrib>Rose, Carsten</creatorcontrib><title>The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>In a population-based study survival after recurrence was compared in three cohorts of patients with a primary diagnosis of breast cancer in 1959, 1969 and 1979, respectively. The use of chemotherapy after recurrence in these cohorts was either none, sporadic or widespread. This allowed a retrospective analysis of the survival impact of chemotherapy. Given the basic assumption that the natural history of breast cancer and the influence of endocrine therapy have not changed significantly during the 20-year period covered by the study, our data suggest that chemotherapy in recurrent breast cancer prolongs survival by 9.5 months in patients who survive more than 2 weeks from the start of treatment for their recurrence.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Survival Analysis</subject><subject>Time Factors</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUc1u1DAYtBCobAuPUMknBFIDnxM7dk6oqviTKnGgnC3H-aw1ysbBdlbaGw_BgefjSXB2V71y-mzPzDfyDCHXDN4yYO27b9CJrlLAu9cg3ihoQFTNE7JhSnYVKFE_JZtHynNymdIPAJCKwwW5UIIpqMWG_HnYIvWTGxecLNLgqN3iLuQtRjMfaJhoWuLe781IjcsYaUS7xHgk-4n2EU3K1Jpyj39__TZ0DvMymuzDVPUm4UBTXobDungurzjlRHMR5YIUffGhrBOQbspoIVEzDeUkIb0gz5wZE748zyvy_eOHh7vP1f3XT1_ubu8ry4XIlWOKMytlI3jT2po3rDW1dU3fy6HllskW0OCAhheo6x0vfGRSoKuVU443V-TVae8cw88FU9Y7nyyOo5kwLElLUfID1RSiOBFtDClFdHqOfmfiQTPQayP62Ihe49Yg9LERvequzwZLv8PhUXWuoODvTziWX-49Rp2sX_MdfMk66yH4_zj8AyHbnG0</recordid><startdate>1993</startdate><enddate>1993</enddate><creator>Cold, Søren</creator><creator>Jensen, Niels V.</creator><creator>Brincker, Hans</creator><creator>Rose, Carsten</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1993</creationdate><title>The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s</title><author>Cold, Søren ; Jensen, Niels V. ; Brincker, Hans ; Rose, Carsten</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-f1841c7735436c24316a2cf3bb7d64c1760eaedea44319bf4184e175ef28f8f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Survival Analysis</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cold, Søren</creatorcontrib><creatorcontrib>Jensen, Niels V.</creatorcontrib><creatorcontrib>Brincker, Hans</creatorcontrib><creatorcontrib>Rose, Carsten</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cold, Søren</au><au>Jensen, Niels V.</au><au>Brincker, Hans</au><au>Rose, Carsten</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>1993</date><risdate>1993</risdate><volume>29</volume><issue>8</issue><spage>1146</spage><epage>1152</epage><pages>1146-1152</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>In a population-based study survival after recurrence was compared in three cohorts of patients with a primary diagnosis of breast cancer in 1959, 1969 and 1979, respectively. The use of chemotherapy after recurrence in these cohorts was either none, sporadic or widespread. This allowed a retrospective analysis of the survival impact of chemotherapy. Given the basic assumption that the natural history of breast cancer and the influence of endocrine therapy have not changed significantly during the 20-year period covered by the study, our data suggest that chemotherapy in recurrent breast cancer prolongs survival by 9.5 months in patients who survive more than 2 weeks from the start of treatment for their recurrence.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>8518025</pmid><doi>10.1016/S0959-8049(05)80305-3</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-8049 |
| ispartof | European journal of cancer (1990), 1993, Vol.29 (8), p.1146-1152 |
| issn | 0959-8049 1879-0852 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_75804083 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Breast Neoplasms - drug therapy Breast Neoplasms - mortality Breast Neoplasms - pathology Cohort Studies Female Humans Middle Aged Neoplasm Recurrence, Local - mortality Survival Analysis Time Factors |
| title | The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T19%3A32%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20influence%20of%20chemotherapy%20on%20survival%20after%20recurrence%20in%20breast%20cancer%E2%80%94a%20population-based%20study%20of%20patients%20treated%20in%20the%201950s,%201960s%20and%201970s&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Cold,%20S%C3%B8ren&rft.date=1993&rft.volume=29&rft.issue=8&rft.spage=1146&rft.epage=1152&rft.pages=1146-1152&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/S0959-8049(05)80305-3&rft_dat=%3Cproquest_cross%3E75804083%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75804083&rft_id=info:pmid/8518025&rft_els_id=S0959804905803053&rfr_iscdi=true |